Bristol-Myers Squibb Company
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Did you know?
Capital expenditures increased by 5% from FY24 to FY25.
Current Price
$58.22
-3.91%GoodMoat Value
$98.93
69.9% undervaluedProfile
Valuation (TTM)
Market Cap$118.56B
P/E16.30
EV$150.48B
P/B6.42
Shares Out2.04B
P/Sales2.45
Revenue$48.48B
EV/EBITDA11.56
Bristol-Myers Squibb Company (BMY) — Earnings Call Transcripts
34 earnings call transcripts available.
Latest Transcript
Read →Q4 2025 Earnings Call
19 speakers9,610 words76 segments